A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

Who May Qualify: - Age 18 years or older - Have documented or reported microscopic hematuria within 3 month of study enrollment - Willing and able to give written willing to sign a consent form Exclusion Criteria (participants must not): - Have history of BCa - History of previous cancer (excluding basal and squamous cell skin cancer) - Have a known active urinary tract infection or urinary retention - Have active stone disease (renal or bladder) or renal insufficiency (creatinine \>2.0 mg/dL) - Have ureteral stents, nephrostomy tubes or bowel interposition - Have recent genitourinary instrumentation (within 10 days prior to signing consent) - Be unable or unwilling to complete the hematuria evaluation (i.e., cystoscopy and upper tract imaging) Always talk to your doctor about whether this trial is right for you.